Get the Stockscreener App
4.13
8.43%
-0.38
After Hours:
4.25
0.12
+2.91%
Artelo Biosciences Inc stock is traded at $4.13, with a volume of 164.61K.
It is down -8.43% in the last 24 hours and down -22.22% over the past month.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
See More
Previous Close:
$4.51
Open:
$4.51
24h Volume:
164.61K
Relative Volume:
1.46
Market Cap:
$2.91M
Revenue:
-
Net Income/Loss:
$-9.60M
P/E Ratio:
-1.307
EPS:
-3.16
Net Cash Flow:
$-8.96M
1W Performance:
-8.02%
1M Performance:
-22.22%
6M Performance:
-16.25%
1Y Performance:
-37.99%
1-Day Range:
$4.00
$4.8273
1-Week Range:
$4.00
$4.97
52-Week Range:
$4.00
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Name
Artelo Biosciences Inc
Sector
Industry
Phone
858-925-7049
Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
4.13 | 9.01M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Feb-12-21 | Initiated | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Stock (ARTL) Latest News
Is Artelo Biosciences Inc. showing signs of accumulationMarket Sentiment Report & Short-Term High Return Strategies - newser.com
Will Artelo Biosciences Inc. see short term momentumMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
Is Artelo Biosciences Inc. stock gaining market shareRisk Management & Verified Technical Signals - newser.com
Real time scanner hits for Artelo Biosciences Inc. explainedJuly 2025 Closing Moves & Community Verified Trade Signals - newser.com
How hedge fund analytics apply to Artelo Biosciences Inc. stockJobs Report & Community Consensus Trade Signals - newser.com
Artelo Biosciences launches public offering; shares down 10% - MSN
Can Artelo Biosciences Inc. stock surprise with earnings upsideJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Is Artelo Biosciences Inc. stock a safe haven assetTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Is Artelo Biosciences Inc. stock a top momentum playAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
What recovery options are there for Artelo Biosciences Inc.July 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com
Will Artelo Biosciences Inc. bounce back from current support2025 Geopolitical Influence & Low Risk High Win Rate Picks - newser.com
What drives Artelo Biosciences Inc stock priceTechnical Pattern Recognition & Small Investment Capital Gains - earlytimes.in
Is Artelo Biosciences Inc a good long term investmentMomentum Stock Picks & Free Rapid Profit Acceleration - earlytimes.in
How to track smart money flows in Artelo Biosciences Inc.Quarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com
Candlestick signals on Artelo Biosciences Inc. stock todayJuly 2025 Opening Moves & Capital Protection Trade Alerts - newser.com
How Artelo Biosciences Inc. stock performs during Fed tightening cyclesMarket Volume Summary & Safe Capital Growth Tips - newser.com
When is the best time to exit Artelo Biosciences Inc.Bull Run & Weekly High Potential Stock Alerts - newser.com
Statistical indicators supporting Artelo Biosciences Inc.’s strengthMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com
Is Artelo Biosciences Inc. stock a defensive play in 2025July 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-05 02:06:03 - newser.com
Artelo Biosciences closes $2 million public offering By Investing.com - Investing.com Canada
Artelo Biosciences closes $2 million public offering - Investing.com India
Artelo Biosciences Announces Closing of $2.0 Million Public Offering - GlobeNewswire
$2M Biotech Funding: Artelo Biosciences Completes Public Offering for Cancer & Pain Drug Development - Stock Titan
Artelo Biosciences prices $2 million public offering of common stock By Investing.com - Investing.com Nigeria
Artelo prices 441,210 shares at $4.40 in underwritten public offering - TipRanks
Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewswire
Artelo Biosciences prices $2 million public offering of common stock - Investing.com India
$2 Million Capital Raise: Artelo Biosciences Prices Public Offering for Cancer Drug Development - Stock Titan
Artelo Biosciences Inc Stock (ARTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):